Novo Nordisk

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments.

CEO

Maziar Mike Doustdar

CEOMaziar Mike Doustdar

Employees

68,794

Employees68,794

Headquarters

Bagsværd, Capital Region

HeadquartersBagsværd, Capital Region

Founded

1923

Founded1923

Employees

68,794

Employees68,794

NVO Key Statistics

Market cap

221.32B

Market cap221.32B

Price-Earnings ratio

11.60

Price-Earnings ratio11.60

Dividend yield

2.49%

Dividend yield2.49%

Average volume

10.68M

Average volume10.68M

High today

$49.64

High today$49.64

Low today

$48.73

Low today$48.73

Open price

$49.17

Open price$49.17

Volume

6.32M

Volume6.32M

52 Week high

$71.80

52 Week high$71.80

52 Week low

$35.12

52 Week low$35.12

NVO News

Simply Wall St 42m

Novo Nordisk Stock May Be 50% Undervalued Despite Medicare GLP 1 Coverage

Novo Nordisk stock has fallen over the past three years, yet current valuation checks point to a company that still screens as cheap, with both its market multi...

The Motley Fool 19h

Is Pfizer on Track to Launch Its Next Lipitor -- This Time in the Weight-Loss Market?

Humans are very bad at taking medications. By some estimates, adherence to long-term chronic medication treatment plans is only around 50%. This is a big issue...

TipRanks 20h

Novo Nordisk Slides As Obesity Trial Shake-Up Alarms Wall Street - TipRanks

...

Analyst ratings

57%

of 37 ratings

Buy

37.8%

Hold

56.8%

Sell

5.4%

More NVO News

TipRanks 1d

Novo Nordisk Tests New Obesity Dose Strategy, Keeping Its Pipeline Momentum

Novo Nordisk (NVO) announced an update on their ongoing clinical study. TipRanks has entered a new arena in the investing world, powering the index of an ETF b...

TipRanks 1d

Cboe data shows mixed options sentiment in Novo Nordisk with shares up 1.22%

Cboe data shows mixed options sentiment in Novo Nordisk (NVO), with shares up 60c, or 1.22%, near $49.48. Options volume relatively light with 24k contracts tra...

Nasdaq 1d

Here's Why Shares in Novo Nordisk Rival, Agios Pharmaceutical, Soared This Week

Key Points Agios stock surged after FDA granted priority review for mitapivat in sickle cell disease. Mitapivat showed mixed Phase 3 results, and competition...

The Motley Fool 2d

Record Numbers of Americans Are on GLP-1 Drugs. That's Great News for This Stock.

GLP-1 drugs are more popular than ever. This week, polling organization Gallup reported that 11% of U.S. adults are currently taking GLP-1 medications for weigh...

TipRanks 2d

Novo Nordisk Halts Device Study for CagriSema: What It Means for NVO Investors

Novo Nordisk (NVO) announced an update on their ongoing clinical study. Unlock powerful investing tools and data-driven insights with TipRanks Premium for more...

Simply Wall St 3d

Novo Nordisk Updates Wegovy Label In Singapore With 21% Weight Loss Data

Novo Nordisk has updated the prescribing label for Wegovy in Singapore using new STEP UP trial data. The trial focused on adults with obesity who do not have d...

Nasdaq 4d

Eli Lilly and Novo Nordisk Are Fine -- but These 2 Stocks Could Be an Even Better Way to Invest in the GLP-1 Boom

Key Points Becton, Dickinson supplies equipment whose demand is soaring due to the rise of GLP-1 medicines. Abbott Laboratories' most important growth driver...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.